Fig. 4: Comparison of 180-day risk for new diagnosis of endocarditis after COVID-19 diagnosis in patients with opioid or cocaine use disorder between propensity-score matched women vs men, Black vs White, Hispanic vs non-Hispanic patients, respectively. | Molecular Psychiatry

Fig. 4: Comparison of 180-day risk for new diagnosis of endocarditis after COVID-19 diagnosis in patients with opioid or cocaine use disorder between propensity-score matched women vs men, Black vs White, Hispanic vs non-Hispanic patients, respectively.

From: Association of COVID-19 with endocarditis in patients with cocaine or opioid use disorders in the US

Fig. 4

Gender, race, and ethnicity cohorts were propensity-score matched for other demographics, adverse socioeconomic determinants of health, comorbidities, medications, medical procedures, and EHR-documented COVID-19 vaccination status.

Back to article page